![](https://d3ilqtpdwi981i.cloudfront.net/QTz_HeBL15boBlawN3JOdEcF_Ko=/0x0:153x198/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/29/f2/81/29f281c0-f4b3-45c9-bf56-935f611dd581/BCCT3.jpg)
Article
A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer
Breast Cancer Research and Treatment
(2013)
Disciplines
Publication Date
April 12, 2013
Citation Information
Reshma Mahtani, Shanu Modi, Cristina Saura, Charles Henderson, et al.. "A Multicenter Trial Evaluating Retaspimycin HCL (IPI-504) Plus Trastuzumab in Patients with Advanced or Metastatic HER2-positive Breast Cancer" Breast Cancer Research and Treatment Vol. 139 (2013) p. 07 - 113 Available at: http://works.bepress.com/reshma-mahtani/76/